1. Home
  2. FLUX vs SNTI Comparison

FLUX vs SNTI Comparison

Compare FLUX & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flux Power Holdings Inc.

FLUX

Flux Power Holdings Inc.

HOLD

Current Price

$1.35

Market Cap

23.3M

Sector

Miscellaneous

ML Signal

HOLD

Logo Senti Biosciences Inc.

SNTI

Senti Biosciences Inc.

HOLD

Current Price

$1.14

Market Cap

24.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLUX
SNTI
Founded
N/A
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.3M
24.5M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
FLUX
SNTI
Price
$1.35
$1.14
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.50
AVG Volume (30 Days)
108.0K
124.0K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
20.00
77.31
EPS
N/A
N/A
Revenue
$9,317,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$23.01
N/A
P/E Ratio
N/A
N/A
Revenue Growth
126.25
N/A
52 Week Low
$0.97
$0.77
52 Week High
$7.55
$5.10

Technical Indicators

Market Signals
Indicator
FLUX
SNTI
Relative Strength Index (RSI) 57.96 71.99
Support Level $1.25 $1.02
Resistance Level $1.52 $1.19
Average True Range (ATR) 0.09 0.07
MACD 0.03 0.04
Stochastic Oscillator 82.35 83.33

Price Performance

Historical Comparison
FLUX
SNTI

About FLUX Flux Power Holdings Inc.

Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications. It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.

About SNTI Senti Biosciences Inc.

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

Share on Social Networks: